Clinical Trial Update: Autologous Stem Cell Transplant for Refractory Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of autologous stem cell transplantation for refractory Crohn's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Autologous stem cell transplantation (autologous stem cell transplantation)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Crohn's Disease | Phase 2 | Status: WITHDRAWN